Loading, Please Wait...

CST: 26/05/2019 04:08:36   

Entasis Therapeutics to Present at H.C. Wainwright & Co. Global Life Sciences Conference in London

53 Days ago

WALTHAM, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Officer, will present at the H.C, Wainwright & Co. Global Life Sciences Conference being held April 7-9, 2019 in London, UK.

Details of the presentation are below:
Event: H.C. Wainwright & Co. Global Life Sciences Conference
Date: Tuesday, April 9, 2019
Time: 11:10 AM GMT / 7:10 AM EDT

In addition to his presentation, Dr. Perros will be hosting 1-on-1 investor meetings at the conference. Investors attending the conference who are interested in meeting with Entasis management should contact their H.C. Wainwright representatives.

About Entasis
Entasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis’ targeted-design platform has produced a pipeline of product candidates, including ETX2514SUL (targeting A. baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae), and ETX0282CPDP (targeting Enterobacteriaceae infections). Entasis is also using its platform to develop a novel class of antibiotics, non-β-lactam inhibitors of the penicillin-binding proteins (NBPs) (targeting Gram-negative infections). For more information, visit www.entasistx.com.

Entasis Company Contact             
Kyle Dow
Entasis Therapeutics
(781) 810-0114
kyle.dow@entasistx.com

Investor Relations Contact
Lee Roth
The Ruth Group
(646) 536-7012
lroth@theruthgroup.com

Media Contact
Kirsten Thomas
The Ruth Group
(508) 280-6592
kthomas@theruthgroup.com

Is your business listed correctly on America’s largest city directory network of 1,000 portals?